Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  12/12/2003
 
Trade Name:  Xenical
 
Generic Name or Proper Name (*):  orlistat
 
Indications Studied:  Obesity management
 
Label Changes Summary:  Use in 12-16 year olds is supported by studies in adults with additional data from a 54 week safety and efficacy study in obese adolescent patients. Since orlistat can reduce absorption of fat soluble vitamins, all patients should take a daily multivitamin supplement containing fat soluble vitamins. Adverse event profile in adolescent patients was similar to that seen in adults
 
Product Labeling:  Labeling  Opens a new window
 
BPCA(B):  B
 
Sponsor:  Roche
 
Pediatric Exclusivity Granted Date:  09/12/2003
 
NNPS:  FALSE'
 
Therapeutic Category:  Obesity management
 
-
-